Hyperlipoproteinemia Type 5 - 13 Studies Found
Terminated |
: MK0859 Dose-Ranging Study (0859-003) :
: 2006-05-11 : Drug: MK0859 |
Completed |
: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients :
|
Withdrawn |
: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction : Mixed Hyperlipoproteinemia : 2014-02-20 :
|
Withdrawn |
: Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid : Mixed Hyperlipidemia : 2013-10-25 :
|
Completed |
: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) : Mixed Hyperlipidemia : 2006-02-07 :
|
Terminated |
: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. : Mixed Hyperlipidemia : 2005-08-22 :
|
Completed |
: A Pilot Study to Evaluate the Lipid Effects of TRIA-662 :
: 2013-12-06 :
|
Completed |
: Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) :
: 2009-07-16 :
|
Completed |
: Lipid Efficacy Study (0524B-022)(COMPLETED) :
: 2005-12-21 :
|
Completed |
: Lipid Efficacy/Tolerability Study (0524A-020) :
: 2005-12-21 :
|